BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 9684800)

  • 1. Native atherosclerosis and vein graft arterialization: association with increased urokinase receptor expression in vitro and in vivo.
    Okada SS; Golden MA; Raghunath PN; Tomaszewski JE; David ML; Kuo A; Kariko K; Barnathan ES
    Thromb Haemost; 1998 Jul; 80(1):140-7. PubMed ID: 9684800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migrating vascular smooth muscle cells polarize cell surface urokinase receptors after injury in vitro.
    Okada SS; Tomaszewski JE; Barnathan ES
    Exp Cell Res; 1995 Mar; 217(1):180-7. PubMed ID: 7867716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
    Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
    Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pulse pressure on vascular smooth muscle cell migration: the role of urokinase and matrix metalloproteinase.
    Redmond EM; Cahill PA; Hirsch M; Wang YN; Sitzmann JV; Okada SS
    Thromb Haemost; 1999 Feb; 81(2):293-300. PubMed ID: 10064009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.
    Fowler B; Mackman N; Parmer RJ; Miles LA
    Thromb Haemost; 1998 Jul; 80(1):148-54. PubMed ID: 9684801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
    Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O
    Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
    Fibbi G; Caldini R; Chevanne M; Pucci M; Schiavone N; Morbidelli L; Parenti A; Granger HJ; Del Rosso M; Ziche M
    Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue.
    Jabs WJ; Theissing E; Nitschke M; Bechtel JF; Duchrow M; Mohamed S; Jahrbeck B; Sievers HH; Steinhoff J; Bartels C
    Circulation; 2003 Sep; 108(12):1428-31. PubMed ID: 12975260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin increases expression of urokinase receptor by activation of the thrombin receptor.
    Yang Z; Cohen RL; Lui GM; Lawrence DA; Shuman MA
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2254-61. PubMed ID: 7558719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells.
    Ueshima S; Fukao H; Okada K; Matsuo O
    Thromb Res; 2004; 113(1):41-9. PubMed ID: 15081564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor.
    Eefting D; de Vries MR; Grimbergen JM; Karper JC; van Bockel JH; Quax PH
    J Vasc Surg; 2010 Feb; 51(2):429-37. PubMed ID: 20036101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombotic gene expression profile in vascular smooth muscle cells of human saphenous vein, but not internal mammary artery.
    Payeli SK; Latini R; Gebhard C; Patrignani A; Wagner U; Lüscher TF; Tanner FC
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):705-10. PubMed ID: 18258816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional inhibition of protease-activated receptor-1 expression by prostacyclin in human vascular smooth muscle cells.
    Pape R; Rauch BH; Rosenkranz AC; Kaber G; Schrör K
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):534-40. PubMed ID: 18162607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.
    Reuning U; Bang NU
    Arterioscler Thromb; 1992 Oct; 12(10):1161-70. PubMed ID: 1327097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of urokinase-type plasminogen activator receptor by IL-1 beta.
    Hasegawa T; Sorensen L; Dohi M; Rao NV; Hoidal JR; Marshall BC
    Am J Respir Cell Mol Biol; 1997 Jun; 16(6):683-92. PubMed ID: 9191470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can be inhibited by alpha2-macroglobulin receptor associated protein.
    Wijnberg MJ; Quax PH; Nieuwenbroek NM; Verheijen JH
    Thromb Haemost; 1997 Aug; 78(2):880-6. PubMed ID: 9268189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells.
    Wojta J; Gallicchio M; Zoellner H; Hufnagl P; Last K; Filonzi EL; Binder BR; Hamilton JA; McGrath K
    Thromb Haemost; 1993 Sep; 70(3):469-74. PubMed ID: 8259551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of protease activated receptor-2 (PAR-2) in balloon-injured rat carotid artery.
    Damiano BP; D'Andrea MR; de Garavilla L; Cheung WM; Andrade-Gordon P
    Thromb Haemost; 1999 May; 81(5):808-14. PubMed ID: 10365757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and significance of urokinase-type plasminogen activator, its receptor, and type 2 inhibitor in giant cell tumor of bone].
    Li H; Dong S; Zeng Y
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):386-8. PubMed ID: 11810768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
    Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
    Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.